By
Drug Target Review2025-06-30T13:30:47
Researchers have developed a new method to generate CAR T cells directly inside the body using targeted lipid nanoparticles that deliver mRNA to T cells - offering a safer, faster and more accessible alternative to traditional cell therapies for cancer and autoimmune diseases.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-20T13:00:00Z
2026-11-20T08:00:00Z
Contributor Dr Rahul Gupta, By Drug Target Review
2023-11-24T12:06:45
Sponsored by Quantum-Si
2026-11-18T07:00:00
Contributor Dr Bryan McClellan and Dr William Matsui, By Drug Target Review
2023-04-12T15:15:18
Sponsored by Cellistic
2023-03-08T16:29:20
Sponsored by Bio-Techne
2026-07-31T06:00:00
Contributor Dr Davinder Ramsingh, By Drug Target Review
Site powered by Webvision Cloud